Aim: Aim of this study to evaluate T2DM patients for awareness of self–monitoring of blood glucose (SMBG) and maintaining optimal blood glucose control in type 2 diabetic patients. Methodology: This was a prospective, non–interventional, observational study, conducted at Department of Pharmacology in association with the Department of Medicine, Dr. S. N. Medical College, Jodhpur. Information pertaining to the patients collected directly from patients or from OPD slip and were noted in case record form and analyzed. Results: Total 250 patients, 77 patients (30.8%) were recorded with age ≤60 years and 173 patients (69.2%) had age more than 60 years. 48.8% of patients had Fasting Blood Glucose ≤130 dg/dl whereas ≥181 mg/dl Post–Prandial Blood Sugar in 83.6% of patients. 199 patients(79.6%) were monitoring their blood glucose between 16 to 30 days. Conclusion: Demographic features of patients with type 2 diabetes treated in primary care are associated with optimal glycemic control. The study strongly highlights the domination of oral hypoglycemic agents but documents shifting trend towards insulin in the treatment of Type 2 diabetes and the need for periodic blood–glucose monitoring in patients receiving anti–diabetic drug treatment to identify inadequately controlled glycemic levels, so that drug therapy can be modyfied and multiple drug interventions can be planned in order to obtain an optimal glycemic level.